louisiana semaglutide intestinal paralysis class action Ozempic Lawsuit [2026 Update] Ozempic GLP-1 Lawsuit & Gastroparesis

View Presentations & Speakers Partner With Us Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals

Although Hims & Hers relationship with Novo may have ended, the company has an existing partnership 3 with Eli Lilly, in which they are permitted to sell Zepbound, a GLP-1 approved by the FDA for weight loss, and Mounjaro, which is not approved for weight loss but for the treatment of type 2 diabetes

Proporciona una solucin de bienestar limpia y conveniente

Adding another set (e.g., doing 3 sets instead of 2)

In addition to addressing the patients expressed goals, frame the conversation in terms of concerns you have about the patients health